American Shared Hospital Services financial data

Symbol
AMS on NYSE
Industry
Services-Medical Laboratories
Location
601 Montgomery Street, Suite 1112, San Francisco, CA
State of incorporation
CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 178 % -38.6%
Debt-to-equity 107 % +23.3%
Return On Equity 13.5 % +687%
Return On Assets 7.07 % +618%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.42M shares +1.91%
Common Stock, Shares, Outstanding 6.39M shares +1.91%
Entity Public Float 11.2M USD
Common Stock, Value, Issued 10.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.48M shares +1.82%
Weighted Average Number of Shares Outstanding, Diluted 6.48M shares +0.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 25M USD +20.8%
Cost of Revenue 13.6M USD +16%
Operating Income (Loss) -568K USD -225%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.69M USD +347%
Income Tax Expense (Benefit) 94K USD -77.9%
Net Income (Loss) Attributable to Parent 3.93M USD +791%
Earnings Per Share, Basic 0.62 USD/shares +786%
Earnings Per Share, Diluted 0.61 USD/shares +771%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.8M USD -4.88%
Accounts Receivable, after Allowance for Credit Loss, Current 8.64M USD +117%
Assets, Current 25.7M USD +26.3%
Operating Lease, Right-of-Use Asset 986K USD +949%
Intangible Assets, Net (Excluding Goodwill) 78K USD 0%
Goodwill 1.27M USD 0%
Other Assets, Noncurrent 394K USD +11.6%
Assets 63.3M USD +33.6%
Accounts Payable, Current 1.79M USD +416%
Employee-related Liabilities, Current 1.22M USD +51.9%
Contract with Customer, Liability, Current 554K USD
Liabilities, Current 17.6M USD +74.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 1.56M USD +89.8%
Operating Lease, Liability, Noncurrent 1.5M USD +13536%
Liabilities 31.4M USD +47.2%
Retained Earnings (Accumulated Deficit) 7.14M USD +122%
Stockholders' Equity Attributable to Parent 26.4M USD +19.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 31.8M USD +22.4%
Liabilities and Equity 63.3M USD +33.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.87M USD -206%
Net Cash Provided by (Used in) Financing Activities 2.28M USD
Net Cash Provided by (Used in) Investing Activities -1.18M USD -466%
Common Stock, Shares Authorized 10M shares 0%
Common Stock, Shares, Issued 6.39M shares +1.91%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -766K USD -202%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.7M USD +25.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 311K USD +22.9%
Deferred Tax Assets, Valuation Allowance 714K USD +2.44%
Deferred Tax Assets, Gross 1.4M USD +23.5%
Operating Lease, Liability 1.74M USD +1746%
Depreciation 1.27M USD +7.02%
Payments to Acquire Property, Plant, and Equipment 1.18M USD +466%
Lessee, Operating Lease, Liability, to be Paid 2.46M USD +2431%
Operating Lease, Liability, Current 235K USD +183%
Lessee, Operating Lease, Liability, to be Paid, Year Two 347K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 346K USD +486%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +60.1%
Deferred Income Tax Expense (Benefit) 5K USD -92.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 720K USD +23900%
Lessee, Operating Lease, Liability, to be Paid, Year Three 347K USD
Deferred Tax Assets, Operating Loss Carryforwards 155K USD +11.5%
Unrecognized Tax Benefits 287K USD +3.24%
Lessee, Operating Lease, Liability, to be Paid, Year Four 348K USD
Operating Lease, Payments 205K USD -44.3%
Depreciation, Depletion and Amortization 1.21M USD -1.54%
Deferred Tax Assets, Net of Valuation Allowance 681K USD +57.3%
Share-based Payment Arrangement, Expense 98K USD +28.9%
Interest Expense 1.36M USD +25.1%